Peripheral Artery Disease Clinical Trial
Official title:
Predicting Procedural and Long-term Outcomes of Endovascular Revascularization for Lower Extremity Peripheral Artery Chronic Total Occlusions With Computed Tomographic Angiography
Nearly one-half of all lower extremity percutaneous interventions performed in patients with
symptomatic peripheral artery disease (PAD) involve chronic total occlusions (CTOs) which are
technically more challenging and are associated with more periprocedural complications and
lower rates of procedural success comparing with non CTOs. Despite innovate dedicated CTO
devices developed and provides higher technical success, a wire-catheter approach to cross
peripheral artery CTO is most often the first choice of operators as its lower cost
advantage.Subhash Banerjee MD reported of all 1,362 CTOs, wire-catheter approaches were used
in 82% and the technical success rate was 65%. If the operators chose wire-catheter as
primary crossing device at the beginning of the procedure, but the technically failed with
the provisional use of re-entry or crossing devices to try to procedural success. Such
procedures add incrementally to procedure duration and cost and the revascularization and
amputation rate at 12 month were highly increased comparing with using dedicated CTO devices
initially. So it is very important to predict the outcome of guidewire crossing through CTOs
to direct the choice of crossing strategy.
Current data suggested that computed tomography angiography (CTA) imaging of PAD and a
detailed comprehensive assessment for CTO arteries before endovascular therapy can assist
preprocedural planning to maximize procedural success. Previous studies about coronary CTOs
prediction scores as the KCCT score and CT-based CT-RECTOR provide the factors including
occlusion length, the shape of proximal entry site, severe calcification, and etc. characters
base on CTA correlating with the outcome of cross. As the same physiopathologic mechanism, we
hypothesized that the radiographic characteristics are connected with outcomes of guidewire
crossing occlusions. To our knowledge, few studies focused on how to predict the successful
GC through peripheral artery CTO, therefore, the purpose of this study was to establish a
simple and clinically applicable prediction model based on CTA characters within the
occlusive lesions and clinical parameters to predict the GC outcomes of patients with lower
extremity CTO.
In addition, the long-term effect of endovascular revascularization are very important. An
analysis concluded that limb adverse event (repeat revascularization rate 17.2%, amputation
rates 8.5%) at 12-month in the CTOs with direct wire-catheter crossing strategy. Base on the
proven influence factors (the lesion length, small diameter of the vessel and severe
calcification, mechanical exposure, etc.)of adverse event at after endovascular
revascularization ,we also can establish model with preoperative computer tomography
angiography that provided the lesion detail characteristic combing the patients' biochemical
and clinical feature to predict the adverse event rate at 12-month after endovascular
revascularization.
Patients Patients with peripheral artery disease met the inclusion criteria if they were PAD
patients, had performed preprocedural CTA and PTA. The hospital's database was used to
identify the patients met inclusion criteria. The medical records and radiologic information
system database were reviewed to retrieve clinical information including background diseases
and radiographic findings.
Computed Tomography Angiography Protocol A 128-section multidetector CT (Philips
brillianceiCT was used for scanning with the following scanning parameters,tube voltage was
120 kVp, tube current 40-440mA, and 0.625-mm slice thicknesses. The protocols required
patients to lie supine with legs extended, A fixed bolus of contrast medium with total volume
of 90 ml (370 mg iodine per milliliter) was injected into antecubital vein at a rate of 4
mL/sec, followed by a 30 mL saline flush, by using a dual-barrel power injector. CT scanning
was performed with the coverage from the common iliac artery bifurcation to the tiptoe.
Scanning began 12 seconds after an attenuation threshold of 150 HU was reached.
CTA Data Analysis CTA data were transferred to an offline workstation for further analysis.
Axial images, cross-sectional views, curved planar reformations (CPR), and multiplanar
reformations (MPR), as well as three-dimensional maximum intensity projection images were
available for evaluation. We measure the degree of transluminal calcification, CT attenuation
value of the proximal occlusion ,anatomic distribution of the leision,and length of
occlusion,and the degree of stenosis CTO Crossing Strategy CTO crossing strategy was
wire-catheter. Technical success was defined as crossing the CTO and placement of a guidewire
in the distal true lumen confirmed by angiography.Outcomes include binary variables of lesion
crossing described as technical success or failure.
Follow-up We also examined patient adverse events after procedures at 12 months: all-cause
death,nonfatal myocardial infarction,revascularization and amputation.
Built prediction model we can establish model with preoperative computer tomography
angiography that provided the lesion detail characteristic combing the patients' biochemical
and clinical feature to predict the procedural and long-term outcomes of endovascular
revascularization for Lower extremity peripheral artery chronic total occlusions.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05712395 -
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
|
N/A | |
Active, not recruiting |
NCT04534257 -
Prospective Registry to Investigate the Safety and Efficacy of the Treatment With the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-Inguinal Disease in Patients With Chronic Limb Threatening Ischemia From Singapore
|
N/A | |
Recruiting |
NCT04511234 -
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
|
N/A | |
Recruiting |
NCT03506633 -
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
|
N/A | |
Active, not recruiting |
NCT03506646 -
Dietary Nitrate Supplementation and Thermoregulation
|
N/A | |
Completed |
NCT02554266 -
Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries
|
||
Completed |
NCT03921905 -
Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes.
|
||
Not yet recruiting |
NCT06369350 -
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
|
Early Phase 1 | |
Recruiting |
NCT04545268 -
Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance
|
N/A | |
Recruiting |
NCT02389023 -
Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery
|
N/A | |
Completed |
NCT02539940 -
Elutax-SV Drug-eluting Balloons for Below-the-knee Treatment
|
||
Completed |
NCT02563535 -
Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos ® in Below-The-Knee Arteries to Treat Critical Limb Ischemia
|
Phase 4 | |
Completed |
NCT02542267 -
In-Stent Restenosis Post-Approval Study
|
N/A | |
Completed |
NCT02522884 -
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
|
N/A | |
Completed |
NCT02228564 -
BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
|
N/A | |
Completed |
NCT02262949 -
A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System
|
N/A | |
Completed |
NCT02145065 -
First-in-man Evaluation of a Novel, Microcrystalline Paclitaxel Coated Balloon for Treatment of Femoropopliteal Artery Disease (PAX-r)
|
N/A | |
Completed |
NCT01743872 -
Optical Imaging Measurement of Intravascular Solution Efficacy Trial
|
N/A | |
Recruiting |
NCT01424020 -
Walking Estimated Limitation Calculated by History - Study 2
|
Phase 4 | |
Active, not recruiting |
NCT01597453 -
NOR-SYS: The Norwegian Stroke in the Young Study
|
N/A |